CLINICAL RESEARCH: VALVULAR HEART DISEASE
Survival Implication of Left Ventricular End-Systolic Diameter in Mitral Regurgitation Due to Flail LeafletsA Long-Term Follow-Up Multicenter Study
Christophe Tribouilloy, MD, PhD*,*,
Francesco Grigioni, MD, PhD ,
Jean François Avierinos, MD ,
Andrea Barbieri, MD ,
Dan Rusinaru, MD*,
Catherine Szymanski, MD*,
Marinella Ferlito, MD ,
Laurence Tafanelli, MD ,
Francesca Bursi, MD ,
Faouzi Trojette, MD*,
Angelo Branzi, MD ,
Gilbert Habib, MD ,
Maria G. Modena, MD ,
Maurice Enriquez-Sarano, MD|| on behalf of the MIDA Investigators
* Department of Cardiology, INSERM, ERI 12, and University Hospital, Amiens, France
Cardiovascular Department, University Hospital of Bologna, Bologna, Italy
Department of Cardiology, University Hospital of Marseille, Marseille, France
Department of Cardiology, University Hospital of Modena, Modena, Italy
|| Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota
Manuscript received December 22, 2008;
revised manuscript received June 3, 2009,
accepted June 9, 2009.
* Reprint requests and correspondence: Prof. Christophe Tribouilloy, INSERM, ERI 12, and University Hospital, Department of Cardiology, Avenue René Laënnec, 80054 Amiens Cedex 1, France (Email: tribouilloy.christophe{at}chu-amiens.fr).
Objectives: This study analyzed the association of left ventricular end-systolic diameter (LVESD) with survival after diagnosis in organic mitral regurgitation (MR) due to flail leaflets.
Background: LVESD is a marker of left ventricular function in patients with organic MR but its association to survival after diagnosis is unknown.
Methods: The MIDA (Mitral Regurgitation International Database) registry is a multicenter registry of echocardiographically diagnosed organic MR due to flail leaflets. We enrolled 739 patients with MR due to flail leaflets (age 65 ± 12 years; ejection fraction: 65 ± 10%) in whom LVESD was measured (36 ± 7 mm).
Results: Under conservative management, 10-year survival and survival free of cardiac death were higher with LVESD <40 mm versus 40 mm (64 ± 5% vs. 48 ± 10%; p < 0.001, and 73 ± 5% vs. 63 ± 10%; p = 0.001). LVESD 40 mm independently predicted overall mortality (hazard ratio [HR]: 1.95, 95% confidence interval [CI]: 1.01 to 3.83) and cardiac mortality (HR: 3.09, 95% CI: 1.35 to 7.09) under conservative management. Mortality risk increased linearly with LVESD >40 mm (HR: 1.15, 95% CI: 1.04 to 1.27 per 1-mm increment). During the entire follow-up (including post-surgical), LVESD 40 mm independently predicted overall mortality (HR: 1.86, 95% CI: 1.24 to 2.80) and cardiac mortality (HR: 2.14, 95% CI: 1.29 to 3.56), due to persistence of excess mortality in patients with LVESD 40 mm after surgery (HR: 1.86, 95% CI: 1.11 to 3.15 for overall death, and HR: 1.81, 95% CI: 1.05 to 3.54 for cardiac death).
Conclusions: In MR due to flail leaflets, LVESD 40 mm is independently associated with increased mortality under medical management but also after mitral surgery. These findings support prompt surgical rescue in patients with LVESD 40 mm but also suggest that best preservation of survival is achieved in patients operated before LVESD reaches 40 mm.
Key Words: mitral regurgitation left ventricular size survival surgery
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | EF = ejection fraction | | LV = left ventricle/left ventricular | | MR = mitral regurgitation | | LVESD = left ventricular end-systolic diameter |
|
Related Articles
-
A New Look to an Old Measurement
- Luc A. Pierard and Julien Magne
J. Am. Coll. Cardiol. 2009 54: 1969-1970.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. Rosenhek
Almanac 2011: valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology
Heart,
December 15, 2011;
97(24):
2007 - 2017.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Van de Heyning, J. Magne, C. J. Vrints, L. Pierard, and P. Lancellotti
The role of multi-imaging modality in primary mitral regurgitation
Eur Heart J Cardiovasc Imaging,
November 29, 2011;
(2011)
jer257v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rusinaru, C. Tribouilloy, F. Grigioni, J. F. Avierinos, R. M. Suri, A. Barbieri, C. Szymanski, M. Ferlito, H. Michelena, L. Tafanelli, et al.
Left Atrial Size Is a Potent Predictor of Mortality in Mitral Regurgitation Due to Flail Leaflets: Results From a Large International Multicenter Study
Circ Cardiovasc Imaging,
September 1, 2011;
4(5):
473 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tribouilloy, D. Rusinaru, C. Szymanski, S. Mezghani, A. Fournier, F. Levy, M. Peltier, A. Ben Ammar, D. Carmi, J.-P. Remadi, et al.
Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive value of left ventricular end-systolic dimension to ejection fraction
Eur Heart J Cardiovasc Imaging,
September 1, 2011;
12(9):
702 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Song, S. H. Kang, E.-J. Lee, M.-J. Shin, J. W. Lee, C. H. Chung, D.-H. Kim, D.-H. Kang, and J.-K. Song
Echocardiographic Predictors of Left Ventricular Function and Clinical Outcomes After Successful Mitral Valve Repair: Conventional Two-Dimensional Versus Speckle-Tracking Parameters
Ann. Thorac. Surg.,
June 1, 2011;
91(6):
1816 - 1823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Adams, J. Chikwe, F. Filsoufi, and A. C. Anyanwu
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol.,
March 29, 2011;
57(13):
1425 - 1444.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Grigioni and A. Branzi
Management of asymptomatic mitral regurgitation
Heart,
December 1, 2010;
96(23):
1938 - 1945.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enriquez-Sarano
To MR or Not to MR: Is That the Question?
J. Am. Coll. Cardiol. Img.,
October 1, 2010;
3(10):
1046 - 1048.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Adams, R. Rosenhek, and V. Falk
Degenerative mitral valve regurgitation: best practice revolution
Eur. Heart J.,
August 2, 2010;
31(16):
1958 - 1966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Magne, P. Lancellotti, and L. A. Pierard
Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation
Circulation,
July 6, 2010;
122(1):
33 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lancellotti, L. Moura, L. A. Pierard, E. Agricola, B. A. Popescu, C. Tribouilloy, A. Hagendorff, J. L. Monin, L. Badano, J. L. Zamorano, et al.
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)
Eur Heart J Cardiovasc Imaging,
May 1, 2010;
11(4):
307 - 332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enriquez-Sarano and T. M. Sundt III
Early Surgery Is Recommended for Mitral Regurgitation
Circulation,
February 16, 2010;
121(6):
804 - 812.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. I. Skopin and I. M. Tsiskaridze
eComment: Optimal management of severe asymptomatic mitral regurgitation
Interact CardioVasc Thorac Surg,
February 1, 2010;
10(2):
305 - 305.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Pierard and J. Magne
A New Look to an Old Measurement
J. Am. Coll. Cardiol.,
November 17, 2009;
54(21):
1969 - 1970.
[Full Text]
[PDF]
|
 |
|
|